Christopher A Caldwell Concentrix Corp (CNXC) insider trading activity

Christopher A Caldwell is President and CEO of Concentrix Corp. Currently has a direct ownership of 241,479 shares of CNXC, which is worth approximately $10.3 Million. The most recent transaction as insider was on Oct 07, 2024, when has been sold 362 shares (Common Stock) at a price of $51.62 per share, resulting in proceeds of $18,686. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 241K

0.98% 3M change

16.64% 12M change

Total Value Held $10.3 Million

Christopher A Caldwell Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 07 2024	SELL Payment of exercise price or tax liability	$18,686 $51.62 p/Share	362 Reduced 0.15%	241,479 Common Stock
Oct 04 2024	SELL Open market or private sale	$517,672 $52.7 p/Share	9,823 Reduced 3.9%	241,841 Common Stock
Oct 04 2024	BUY Exercise of conversion of derivative security	$405,809 $31.39 p/Share	12,928 Added 4.89%	251,664 Common Stock
Oct 02 2024	SELL Payment of exercise price or tax liability	$20,266 $51.7 p/Share	392 Reduced 0.16%	238,736 Common Stock
Apr 19 2024	BUY Open market or private purchase	$49,131 $54.59 p/Share	900 Added 0.37%	239,128 Common Stock
Feb 01 2024	BUY Grant, award, or other acquisition	-	40,322 Added 14.48%	238,228 Common Stock
Jan 27 2024	SELL Payment of exercise price or tax liability	$137,378 $92.2 p/Share	1,490 Reduced 0.75%	197,906 Common Stock
Jan 26 2024	SELL Payment of exercise price or tax liability	$97,091 $91.08 p/Share	1,066 Reduced 0.53%	199,396 Common Stock
Dec 01 2023	SELL Payment of exercise price or tax liability	$621,440 $94.53 p/Share	6,574 Reduced 3.18%	200,462 Common Stock
Oct 11 2023	SELL Payment of exercise price or tax liability	$46,973 $82.41 p/Share	570 Reduced 0.27%	207,036 Common Stock
Oct 07 2023	SELL Payment of exercise price or tax liability	$29,141 $80.5 p/Share	362 Reduced 0.17%	207,606 Common Stock
Oct 02 2023	SELL Payment of exercise price or tax liability	$31,473 $80.29 p/Share	392 Reduced 0.19%	207,968 Common Stock
Jan 27 2023	BUY Grant, award, or other acquisition	-	24,465 Added 10.51%	208,360 Common Stock
Jan 26 2023	SELL Payment of exercise price or tax liability	$147,776 $141.82 p/Share	1,042 Reduced 0.56%	183,895 Common Stock
Dec 01 2022	SELL Payment of exercise price or tax liability	$800,253 $121.73 p/Share	6,574 Reduced 3.43%	184,937 Common Stock
Oct 11 2022	SELL Payment of exercise price or tax liability	$68,463 $120.11 p/Share	570 Reduced 0.3%	191,511 Common Stock
Oct 07 2022	SELL Payment of exercise price or tax liability	$43,639 $120.55 p/Share	362 Reduced 0.19%	192,081 Common Stock
Oct 03 2022	SELL Payment of exercise price or tax liability	$24,325 $117.51 p/Share	207 Reduced 0.11%	192,443 Common Stock
Oct 02 2022	SELL Payment of exercise price or tax liability	$107,757 $117.51 p/Share	917 Reduced 0.47%	192,650 Common Stock
Feb 07 2022	SELL Payment of exercise price or tax liability	$945,843 $198.79 p/Share	4,758 Reduced 2.4%	193,567 Common Stock
Feb 07 2022	BUY Grant, award, or other acquisition	-	14,007 Added 6.6%	198,325 Common Stock
Jan 26 2022	BUY Grant, award, or other acquisition	-	16,536 Added 8.23%	184,318 Common Stock
Dec 01 2021	SELL Payment of exercise price or tax liability	$1,083,001 $164.74 p/Share	6,574 Reduced 3.77%	167,782 Common Stock
Oct 20 2021	SELL Payment of exercise price or tax liability	$1,030,438 $184.27 p/Share	5,592 Reduced 3.11%	174,356 Common Stock
Oct 20 2021	BUY Grant, award, or other acquisition	-	14,209 Added 7.32%	179,948 Common Stock

Also insider at

SNX

TD SYNNEX CORP Technology

President, Concentrix

CAC